Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 7Recruiting 3Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Nasopharyngeal Carcinoma 1Melanoma 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Nicotine Replacement Therapy × Clear all
NCT04899492 2024-11-07

RESPIRE

Institut Cancerologie de l'Ouest

Phase NA Terminated
22 enrolled
BreastDermatologicGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Melanoma, Smoking Cessation

NCT02582008 2023-03-22

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
9 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡